JOHN GIVOGRE: Open Payments
NPI 1740263011 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$657 in 32 payments from 14 companies in 2025. Trend: 2023 $1,271 · 2024 $594 · 2025 $657
Food & beverage: $657
| Company | Payments | Amount |
|---|---|---|
| Virtus Pharmaceuticals LLC | 6 | $124 |
| Collegium Pharmaceutical, Inc. | 7 | $114 |
| Globus Medical, Inc. | 3 | $82 |
| ABBVIE INC. | 3 | $64 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Stryker Corporation | 1 | $45 |
| BIOTRONIK NRO, Inc. | 2 | $44 |
| MML US, Inc. | 2 | $28 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $26 |
| Curonix LLC | 1 | $18 |
Products named: LEVORPHANOL TARTRATE, Belbuca, Senza, BOTOX, RELISTOR, OPTABLATE, Prospera, ReActiv8.
Industry payments across GA — which companies pay providers there.
